SPRAGUE JOHN M (Chief Financial Officer) reported 1 transaction at T2 BIOSYSTEMS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/24/2018ACC: 0000899243-18-020506
Officer· Chief Financial Officer
Since Jul 2018
-5.62K
Net shares
Net seller
$37.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.62K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.62K
Price / share
$6.72
Trade value
$37.76K
% of position
32.5%
7/20/2018
17.29K→11.67K
Total
Net shares
−5.62K
Net value
-$37.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/20/2018 | F · Tax Withholding | −5.62K | $6.72 | $37.76K | 32.5% | 17.29K | 11.67K |
| Total | −5.62K | -$37.76K | ||||||
Derivative Transactions0
No derivative transactions reported